Press Releases for 2023

ZOLL remedē System, a Breakthrough Therapy for Treating Central Sleep Apnea, Receives Approval for MRI Conditional Use

Wednesday, May 24, 2023 in Chelmsford, Mass.

Results from Benefit of Microcor in Acute Decompensated Heart Failure (BMAD) Trial Presented as ACC.23/WCC Late-Breaking Clinical Trial

Monday, March 6, 2023 in Chelmsford, Mass.

First Patient Enrolled in REAL SSO2 Study to Evaluate Clinical Utility and Economic Value of ZOLL TherOx SSO2 Therapy

Tuesday, January 17, 2023 in Chelmsford, Mass.